Skip to main content

Table 1 Clinical data of patients with or without ALI after CPB surgery

From: Association of apolipoprotein A1 -75 G/A polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery

Variable ALI Without ALI P
Total no. 300 300  
Age (years) 59.1 ± 10.6 56.8 ± 9.4 0.005
Gender (Male/Female) 205/95 201/99 0.73
ASA 2.77 ± 0.71 2.67 ± 0.65 0.07
NYHA 2.69 ± 0.67 2.57 ± 0.55 0.02
LVEF (%) 59.68 ± 7.94 60.68 ± 8.04 0.13
Previous cardiac surgery (%) 45 (15.0) 30 (10.0) 0.07
Hypertension (%) 75 (25.0) 70 (23.3) 0.63
Diabetes mellitus (%) 26 (8.7) 24 (8.0) 0.77
Obesity (%) 70 (23.3) 48 (16.0) 0.03
Peripheral vascular disease (%) 43 (14.3) 26 (8.7) 0.03
Transfusion (mL) 694.3 ± 103.7 687.3 ± 99.8 0.40
Duration of operation (min) 231.7 ± 90.1 210.5 ± 82.3 0.003
Duration of CPB (min) 106.7 ± 43.7 99.5 ± 41.5 0.04
Duration of cross-clamp (min) 62.1 ± 32.4 60.7 ± 31.9 0.59
Surgery    
  Valvular surgery (%) 176 (58.7) 183 (61.0) 0.56
  CABG surgery (%) 99 (33.0) 102 (34.0) 0.80
  Aortic surgery (%) 25 (8.3) 15 (5.0) 0.11
  1. ALI, Acute lung injury; CPB, Cardiopulmonary bypass; ASA, American Society of Anesthesiology; NYHA, New York Heart Association; LVEF, Left ventricular ejection fraction; CABG, Coronary artery bypass graft.